Einzelansicht Rollinger

[Back]

Univ.-Prof. Mag. Dr. Judith Maria Rollinger

T: +43-1-4277-55255

judith.rollinger@univie.ac.at

Winter term 2025

251032 VO Pharmakognosie (biogene Arzneimittel, med. Aspekte)

321001 VO Steop Einführung in die pharmazeutischen Wissenschaften - B1

321036 PR Drogenanalyse - B19 - (5 Kurse)

322001 VO (Bio)pharma. mit Wirkung auf metabol. Störungen & eingeschr. Organ- und Systemfunktionen - M1

322002 VO Antiinfektiva, Antineoplastika und (Bio)pharmazeutika mit Wirkung auf das Immunsystem - M2

322028 VU Ausgewählte Kapitel aus der pharmakognostischen Forschung - M13

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1

323002 UE Introduction to Experimental Methods in Drug Discovery and Preclinical Drug Development - MPS1

580003 SE SE Journal Club: phytochemistry and bioactive natural products

580007 SE SE Academic training and discussion in Pharmacognosy - for doctoral students

Summer term 2025

321036 PR Drogenanalyse - B19 - (5 Kurse)

322005 VO (Bio)pharmazeutika mit Wirkung auf das Herz-Kreislauf System - M4

322006 VO (Bio)pharmazeutika mit Wirkung auf das Nervensystem - M5

322028 VU Ausgewählte Kapitel aus der pharmakognostischen Forschung - M13

322563 VU Phytotherapy: from bench to bedside - M14 - (incl. Exkursion)

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1

323002 UE Introduction to Experimental Methods in Drug Discovery and Preclinical Drug Development - MPS1

323007 UE Experimental Methods in Drug Discovery und Preclinical Drug Development - MPS6 - (2 Courses)

580001 SE Journal Club: phytochemistry and bioactive natural products

580005 VU Academic training and discussion in Pharmacognosy - for doctoral students

Winter term 2024

251032 VO Pharmakognosie (biogene Arzneimittel, med. Aspekte)

321001 VO Steop Einführung in die pharmazeutischen Wissenschaften - B1

321036 PR Drogenanalyse - B19 - (5 Kurse)

322001 VO (Bio)pharma. mit Wirkung auf metabol. Störungen & eingeschr. Organ- und Systemfunktionen - M1

322002 VO Antiinfektiva, Antineoplastika und (Bio)pharmazeutika mit Wirkung auf das Immunsystem - M2

322028 VU Ausgewählte Kapitel aus der pharmakognostischen Forschung - M13

322061 VU Pharmakobotanische Exkursion nach La Gamba/Costa Rica - M14

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1

323002 UE Introduction to Experimental Methods in Drug Discovery and Preclinical Drug Development - MPS1

580003 SE SE Journal Club: phytochemistry and bioactive natural products

580007 SE SE Academic training and discussion in Pharmacognosy - for doctoral students

Ladurner A, Atanasov AG, Heiss EH, Baumgartner L, Schwaiger S, Rollinger JM et al. 2-(2,4-dihydroxyphenyl)-5-(E)-propenylbenzofuran promotes endothelial nitric oxide synthase activity in human endothelial cells. Biochemical Pharmacology. 2012;84(6):804-812. doi: 10.1016/j.bcp.2012.06.029

Bauer J, Kuehnl S, Rollinger JM, Scherer O, Northoff H, Stuppner H et al. Carnosol and carnosic acids from Salvia officinalis inhibit microsomal prostaglandin E<inf>2</inf>synthase-1. Journal of Pharmacology and Experimental Therapeutics. 2012;342(1):169-176. doi: 10.1124/jpet.112.193847

Bauer J, Waltenberger B, Noha SM, Schuster D, Rollinger JM, Boustie J et al. Discovery of Depsides and Depsidones from Lichen as Potent Inhibitors of Microsomal Prostaglandin E2 Synthase-1 Using Pharmacophore Models. ChemMedChem. 2012;7(12):2077-2081. doi: 10.1002/cmdc.201200345

Grienke U, Schmidtke M, von Grafenstein S, Kirchmair J, Liedl KR, Rollinger JM. Influenza neuraminidase: A druggable target for natural products. Natural Product Reports - NPR. 2012;29(1):11-36. doi: 10.1039/c1np00053e

Heiss EH, Baumgartner L, Schwaiger S, Heredia RJ, Atanasov AG, Rollinger JM et al. Ratanhiaphenol III from Ratanhiae Radix is a PTP1B Inhibitor. Planta Medica: natural products and medicinal plant research. 2012;78(7):678-681. doi: 10.1055/s-0031-1298242

Schuster D, Markt P, Grienke U, Mihaly-Bison J, Binder M, Noha SM et al. Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation. Bioorganic & Medicinal Chemistry. 2011 Dec 1;19(23):7168-7180. doi: 10.1016/j.bmc.2011.09.056

Grienke U, Mihaly-Bison J, Schuster D, Afonyushkin T, Binder M, Guan S et al. Pharmacophore-based discovery of FXR-agonists. Part II: Identification of bioactive triterpenes from Ganoderma lucidum. Bioorganic & Medicinal Chemistry. 2011 Nov 15;19(22):6779-6791. doi: 10.1016/j.bmc.2011.09.039

Grienke U, Bison MJ, Schuster D, Guo D, Guan S, Cheng C et al. In silico approaches to identify FXR-inducing constituents from Ganoderma lucidum - the Chinese mushroom of immortality. Planta Medica: natural products and medicinal plant research. 2011 Aug;77(12):1243-1244.

Schmidtke M, Rollinger JM , Grienke U, Seidel N, Krumbholz A, Wutzler P et al. Discovery of Novel Natural Neuraminidase Inhibitors (NAI) based on In Silico Screening and Antiviral Investigations. Antiviral Research. 2011 May;90(2):A42-A42. doi: 10.1016/j.antiviral.2011.03.064

Kirchmair J, Distinto S, Liedl KR, Markt P, Rollinger JM, Schuster D et al. Development of anti-viral agents using molecular modeling and virtual screening techniques. Infectious Disorders, Drug Targets. 2011;11(1):64-93. doi: 10.2174/187152611794407782

Pfisterer PH, Shen C, Nikolovska-Coleska Z, Schyschka L, Schuster D, Rudy A et al. In silico discovery of acylated flavonol monorhamnosides from Eriobotrya japonica as natural, small-molecular weight inhibitors of XIAP BIR3. Bioorganic & Medicinal Chemistry. 2011;19(2):1002-1009. doi: 10.1016/j.bmc.2010.10.046

Kirchmair J , Rollinger JM, Liedl KR, Seidel N, Krumbholz A, Schmidtke M. Novel neuraminidase inhibitors: Identification, biological evaluation and investigations of the binding mode. Future Medicinal Chemistry. 2011;3(4):437-450. doi: 10.4155/fmc.10.292

Waltenberger B, Wiechmann K, Markt P, Noha SM, Wolber G, Rollinger JM et al. Pharmacophore modeling and virtual screening for novel acidic inhibitors of microsomal prostaglandin E<inf>2</inf> synthase-1 (mPGES-1). Journal of Medicinal Chemistry. 2011;54(9):3163-3174. doi: 10.1021/jm101309g

Waltenberger B, Rollinger JM, Griesser UJ, Stuppner H, Gelbrich T. Plumeridoid C from the Amazonian traditional medicinal plant Himatanthus sucuuba. Acta Crystallographica Section C: Crystal Structure Communications. 2011;67:o409-o412. doi: 10.1107/S0108270111035761

Waltenberger B, Schuster D, Paramapojn S, Gritsanapan W, Wolber G, Rollinger JM et al. Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: Identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine. Phytomedicine. 2011;18(2-3):119-133. 18. doi: 10.1016/j.phymed.2010.08.002

Hornick A, Lieb A, Vo NP, Rollinger JM, Stuppner H, Prast H. The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory. Neuroscience. 2011;197:280-292. doi: 10.1016/j.neuroscience.2011.09.006

Rollinger JM, Schmidtke M. The human rhinovirus: Human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery. Medicinal Research Reviews. 2011;31(1):42-92. doi: 10.1002/med.20176

Grienke U, Schmidtke M, Kirchmair J, Stuppner H, Liedl K, Rollinger J. Discovery of novel neuraminidase inhibiting scaffolds from Alpinia katsumadai. Planta Medica: natural products and medicinal plant research. 2010 Aug;76(12):1179-1179.

Schuster D, Spetea M, Music M, Rief S, Fink M, Kirchmair J et al. Morphinans and isoquinolines: Acetylcholinesterase inhibition, pharmacophore modeling, and interaction with opioid receptors. Bioorganic & Medicinal Chemistry. 2010 Jul 15;18(14):5071-5080. doi: 10.1016/j.bmc.2010.05.071

Grienke U, Schmidtke M, Kirchmair J, Pfarr K, Wutzler P, Duerrwald R et al. Antiviral Potential and Molecular Insight into Neuraminidase Inhibiting Diarylheptanoids from Alpinia katsumadai. Journal of Medicinal Chemistry. 2010 Jan 28;53(2):778-786. doi: 10.1021/jm901440f

The potential of polypore extracts to modulate angiogenesis and inflammation: Insights from in vitro screening on endothelial cell proliferation, migration, and leukocyte recruitment

Achenbach, J. (Contributor), Wasilewicz, A. (Contributor), Roggio, A. (Contributor), Grienke, U. (Contributor), Beniddir, M. A. (Contributor), Rollinger, J. M. (Contributor), Fürst, R. (Contributor) & Kirchweger, B. (Speaker)

3 Sept 2025